Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy PF-06939926

Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy PF-06939926

NEW YORK–(BUSINESS WIRE)–October 01, 2020 — Pfizer Inc. (NYSE: PFE) today announce...
read more
Telix Pharmaceuticals Submits New Drug Application to US FDA for Prostate Cancer Imaging Product

Telix Pharmaceuticals Submits New Drug Application to US FDA for Prostate Cancer Imaging Product

MELBOURNE, Australia and INDIANAPOLIS, Sept. 24, 2...
read more
Yale’s rapid COVID-19 saliva test receives FDA emergency use authorization

Yale’s rapid COVID-19 saliva test receives FDA emergency use authorization

A saliva-based laboratory diagnostic test develope...
read more
FDA Approves Twirla

FDA Approves Twirla

FDA Approves Twirla (levonorgestrel and ethinyl es...
read more
FDA Approves Pemfexy

FDA Approves Pemfexy

FDA Approves Pemfexy (pemetrexed for injection) as...
read more
FDA Approves Audenz

FDA Approves Audenz

FDA Approves Audenz (Influenza A (H5N1) Monovalent...
read more
FDA wants stronger warning on breast implants about risks

FDA wants stronger warning on breast implants about risks

U.S. health officials want women getting breast im...
read more
Supplements for Brain Health Don't Work, According to Neurologist

Supplements for Brain Health Don't Work, According to Neurologist

Americans and others around the world have turned ...
read more
FDA approves first drug to help tame cluster headaches

FDA approves first drug to help tame cluster headaches

(HealthDay)— The U.S. Food and Drug Administrati...
read more
FDA approves first gene therapy for spinal muscular atrophy

FDA approves first gene therapy for spinal muscular atrophy

(HealthDay)—The first gene therapy has been appr...
read more